AsclepiX Therapeutics (United States)

Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovascularization and vascular leakage

Raquel Lima e Silva, Yogita Kanan, Adam C. Mirando et al. · Science Translational Medicine · 2017 · 59 citations · Full text

Medicine, Molecular Medicine, Ophthalmology +16

A collagen IV–derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling

Adam C. Mirando, Jikui Shen, Raquel Lima e Silva et al. · JCI Insight · 2019 · 54 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple‐negative breast cancer cells

Eric M. Bressler, Jayoung Kim, Ron B. Shmueli et al. · Journal of Biomedical Materials Research Part A · 2018 · 47 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

Adam C. Mirando, Akash Patil, Christine I. Rafie et al. · OncoImmunology · 2020 · 20 citations · Full text

Medicine, Immunology, Oncology +17

Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling

Adam C. Mirando, Raquel Lima e Silva, Zenny Chu et al. · International Journal of Molecular Sciences · 2020 · 20 citations · Full text

Medicine, Ophthalmology, Pharmacology +17